Vimarsana
Biggest News Aggregation in the World

Page 2 - Second Harmonic Generation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Second Harmonic Generation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Second Harmonic Generation Today - Breaking & Trending Today

Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief - Vimarsana News

Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief

– US board-certified medical oncologist with extensive global clinical and regulatory experience advancing oncology medicines from early development stages...

HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction in Steatosis & Hepatocyte Ballooning in FLIGHT-FXR NASH Clinical Trial - Vimarsana News

HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction in Steatosis & Hepatocyte Ballooning in FLIGHT-FXR NASH Clinical Trial

/PRNewswire/ -- HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announced that its AI-based qFibrosis®, qSteatosis®...

Coupler Boosts On-Chip Second-Harmonic Generation | Jul 2022 - Vimarsana News

Coupler Boosts On-Chip Second-Harmonic Generation | Jul 2022

Researchers at Sun Yat-sen University and Nanjing University designed and fabricated a thin-film lithium niobate (TFLN) edge coupler that will allow T

HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials - Vimarsana News

HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials

This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a...

HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology - Vimarsana News

HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology

/PRNewswire/ -- HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, has announced a collaboration with Galecto, Inc., a...